GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Circio Holding ASA (FRA:TA50) » Definitions » Sale Of Investment

Circio Holding ASA (FRA:TA50) Sale Of Investment : €0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Circio Holding ASA Sale Of Investment?

Circio Holding ASA's sale of investment for the three months ended in Dec. 2023 was €0.00 Mil. It means Circio Holding ASA gained €0.00 Mil from selling investments. Circio Holding ASA's sale of investment for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Jun. 2023 ), Circio Holding ASA gained the same money from selling investments in Dec. 2023 (€0.00 Mil).


Circio Holding ASA Sale Of Investment Historical Data

The historical data trend for Circio Holding ASA's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Circio Holding ASA Sale Of Investment Chart

Circio Holding ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Circio Holding ASA Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Dec23
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Circio Holding ASA Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Circio Holding ASA Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Circio Holding ASA's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Circio Holding ASA (FRA:TA50) Business Description

Traded in Other Exchanges
Address
Vollsveien 19, Lysaker, Oslo, NOR, 1366
Circio Holding ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. Its product candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to infect cancer cells and activate the immune system to fight cancer. It includes the development and implementation with the purpose of developing targeted immunotherapy treatments for cancer patients.

Circio Holding ASA (FRA:TA50) Headlines

No Headlines